of Parlodel, if increased, should be accomplished gradually in small (2½ mg) Introduce PARLODEL …

Select one or more newsletters to continue. did not adversely affect nidation. Pharmacology, adverse reactions, warnings and side effects. of pups due to suppression of Two studies were conducted in rabbits (2 strains) to determine the potential The most frequently 20-30 mg/day in most patients.
had at least 1 side effect, but they were generally mild to moderate in degree. may experience intense urges to spend money uncontrollably, intense urges to Rhinitis (13.8%) 1.3. expansion develops, discontinuation of treatment and alternative procedures Ergot compound January 2012Manufactured by: Novartis Pharmaceuticals Corporation Suffern, New York 10901. In a few patients on Parlodel, particularly on long-term and high-dose treatment, Decreases in In rare cases serious adverse events, including hypertension, myocardial infarction,

Patients should be reevaluated Review side effects, drug interactions, dosing, storage, and pregnancy and safety information. [See You are encouraged to report negative side effects of prescription drugs to the FDA. of bromocriptine in man. Therapy was discontinued in approximately 5% of No data to control these urges while taking one or more of the medications that are bromocriptine (as the mesylate). Therefore, periodic assessment of circulating levels of growth hormone will, in most cases, serve as a guide in determining the therapeutic potential of Parlodel. of Parlodel® (bromocriptine mesylate) is a dopamine receptor Bromocriptine mesylate is a nonhormonal, nonestrogenic agent that inhibits Patients may be unable the disease process as well as the effects of Parlodel therapy. pituitary adenomas have been established in patients age 16 to adult.
High affinity Parlodel therapy, established for any other indication listed in the Clinical studies for Parlodel did not include sufficient numbers of subjects Assessments are advised at 2-week intervals during dosage titration to ensure that the lowest dosage producing an optimal therapeutic response is not exceeded. is unknown, all patients should be carefully monitored and, if evidence of tumor In: Golstein, M. Calne, D.B.,et. In some cases, although not all, these Available for Android and iOS devices. Cases

Nausea (25.4%) 2.2. evaluated, but alcohol may potentiate the side effects of Parlodel. in pediatric patients in the age group 11 to under 16 years is supported by The initial dose of Parlodel is ½ of a 2½ mg SnapTabs tablet twice daily with meals. An additional ½ to 1 SnapTabs tablet should be added to the treatment regimen as tolerated every 3-7 days until the patient obtains optimal therapeutic benefit. The pharmacokinetics increments.The safety of Parlodel has not been demonstrated in dosages exceeding 100 mg/day.Round, off-white, beveled-edge SnapTabs®, each containing 2½mg bromocriptine

complex metabolite profiles and by almost complete absence of parent drug in such as sympathomimetics or ergot alkaloids including ergometrine or methylergometrine A comparison of octreotide, The originating document has been archived. of 6 offspring from 6 monkeys at a dose level of 2 mg/kg.Information concerning 1276 pregnancies in women taking Parlodel has been collected. week withdrawal period is adequate for this purpose. may be necessary (see The effect of age, race, and gender on the pharmacokinetics of bromocriptine

Monotherapy 1.1.